Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.
The monovalent cation lithium partially exerts its effects by activating neurotrophic and neuroprotective cellular cascades. Here, we discuss the effects of lithium on oxidative stress, programmed cell death (apoptosis), inflammation, glial dysfunction, neurotrophic factor functioning, excitotoxicity, and mitochondrial stability. In particular, we review evidence demonstrating the action of lithium on cyclic adenosine monophosphate (cAMP)-mediated signal transduction, cAMP response element binding activation, increased expression of brain-derived neurotrophic factor, the phosphatidylinositide cascade, protein kinase C inhibition, glycogen synthase kinase 3 inhibition, and B-cell lymphoma 2 expression. Notably, we also review data from clinical studies demonstrating neurotrophic effects of lithium. We expect that a better understanding of the clinically relevant pathophysiological targets of lithium will lead to improved treatments for those who suffer from mood as well as neurodegenerative disorders.
Quiroz
Jorge A
JA
Hoffman-La Roche Inc., Pharma Development and Exploratory Neuroscience, Nutley, NJ, USA.
Machado-Vieira
Rodrigo
R
Zarate
Carlos A
CA
Manji
Husseini K
HK
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D006801:Humans; D018020:Lithium Compounds / Q000494:pharmacology*; D009414:Nerve Growth Factors / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000494:pharmacology*
D014150:Antipsychotic Agents; D018020:Lithium Compounds; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents
J Biol Chem. 1988 Oct 5;263(28):14559-65
2844776
Pharmacol Biochem Behav. 1998 Jan;59(1):191-200
9443555
Mol Psychiatry. 2002;7(8):845-50
12232777
Trends Neurosci. 1988 Mar;11(3):117-23
2465609
Neuropsychopharmacology. 1999 Oct;21(4):519-29
10481836
Neuropsychopharmacology. 2008 May;33(6):1229-38
17687266
Arch Biochem Biophys. 1974 Sep;164(1):194-201
4372945
Biol Psychiatry. 2004 Oct 1;56(7):467-75
15450781
Biochemistry. 1984 Jan 17;23(2):252-60
6230103
Trends Pharmacol Sci. 2003 Sep;24(9):441-3
12967765
J Neurochem. 2001 May;77(3):796-803
11331408
J Clin Psychiatry. 2009 Apr 21;70(5):699-705
19389332
J Neurosci. 2004 Jul 28;24(30):6791-8
15282284
J Biol Chem. 1980 Nov 25;255(22):10896-901
6253491
J Mol Neurosci. 2001 Apr-Jun;16(2-3):243-61; discussion 279-84
11478380
Eur J Neurosci. 2002 May;15(10):1681-91
12059976
Biol Psychiatry. 1999 Oct 1;46(7):929-40
10509176
Behav Pharmacol. 2006 Jun;17(4):311-8
16914949
J Neurochem. 1999 Feb;72(2):879-82
9930766
Psychopharmacol Bull. 2001 Spring;35(2):5-49
12397885
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11824-8
11553785
Bipolar Disord. 2002 Apr;4(2):129-36
12071510
Biochim Biophys Acta. 1993 Jun 30;1177(3):253-69
8391849
Neuroreport. 1999 Dec 16;10(18):3887-90
10716228
Brain Res. 2004 Oct 22;1024(1-2):183-92
15451381
J Neurochem. 1995 Dec;65(6):2500-8
7595544
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8455-9
8710892
Int J Neuropsychopharmacol. 2007 Feb;10(1):63-71
16420717
J Neurosci. 2003 Aug 13;23(19):7311-6
12917364
Mol Psychiatry. 2002;7 Suppl 1:S46-56
11986995
Int J Neuropsychopharmacol. 2007 Feb;10(1):7-19
16672106
Cell. 1989 Nov 3;59(3):411-9
2553271
J Neurochem. 1997 Dec;69(6):2336-44
9375664
Int J Neuropsychopharmacol. 2003 Sep;6(3):225-31
12974988
Int J Neuropsychopharmacol. 2007 Aug;10(4):491-6
16923323
Biochem Biophys Res Commun. 2001 Jan 26;280(3):720-5
11162580
Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):193-201
15950778
Biol Psychiatry. 2004 Apr 15;55(8):781-4
15050857
Neurosci Lett. 1996 Dec 20;220(3):171-4
8994220
Neuropsychopharmacology. 2008 Jan;33(2):361-7
17406649
Biochem J. 1982 Sep 15;206(3):587-95
7150264
Bipolar Disord. 2009 Jun;11 Suppl 2:92-109
19538689
J Neurosci. 2005 May 4;25(18):4493-502
15872096
Annu Rev Pharmacol Toxicol. 2009;49:327-47
18928402
Neurochem Res. 1998 Jun;23(6):887-92
9572678
Psychopharmacology (Berl). 2007 Dec;195(3):357-67
17705060
Neuropharmacology. 2007 Sep;53(4):487-95
17686496
Curr Drug Targets. 2006 Nov;7(11):1421-34
17100582
Neuropharmacology. 2002 Dec;43(7):1173-9
12504924
J Neural Transm (Vienna). 2007;114(4):405-16
16906355
J Biol Chem. 1992 Aug 25;267(24):16878-82
1324914
Arch Gen Psychiatry. 2008 Mar;65(3):255-63
18316672
Neuropsychopharmacology. 2004 Jan;29(1):32-8
12942141
Behav Pharmacol. 2008 May;19(3):217-24
18469539
J Neurosci. 2008 Mar 5;28(10):2576-88
18322101
Mol Psychiatry. 1999 Jan;4(1):21-5
10089004
Psychopharmacology (Berl). 2001 Oct;158(1):100-6
11685390
Biochem Pharmacol. 1982 Mar 15;31(6):1025-31
6211175
Trends Neurosci. 1995 Feb;18(2):64-5
7537411
J Psychosom Res. 2002 Aug;53(2):687-97
12169343
Biol Psychiatry. 2002 Sep 1;52(5):404-12
12242056
Neuropsychopharmacology. 1996 Oct;15(4):370-81
8887991
FEBS Lett. 1997 Jul 14;411(2-3):183-8
9271202
J Neurochem. 1996 Aug;67(2):767-77
8764606
Clin Neurosci Res. 2002 Dec;2(3-4):193-212
22707923
Bipolar Disord. 2002 Apr;4(2):137-44
12071511
Biochem J. 2000 Oct 1;351(Pt 1):95-105
10998351
Arch Gen Psychiatry. 2000 Jan;57(1):95-7
10632242
Mol Psychiatry. 2009 Jan;14(1):51-9
17925795
Arch Gen Psychiatry. 2002 Jul;59(7):592-6
12090811
J Clin Psychiatry. 2004 Jan;65(1):10-21
14744163
J Psychiatr Res. 2008 Apr;42(5):416-21
17512948
J Biol Chem. 1999 Mar 5;274(10):6039-42
10037682
Autophagy. 2008 May;4(4):527-30
18367867
Neuropsychopharmacology. 2008 Oct;33(11):2551-65
18235426
Biol Psychiatry. 2000 Jul 1;48(1):1-8
10913502
Am J Psychiatry. 2008 Mar;165(3):313-20
18245175
Mol Psychiatry. 2002;7(6):604-8
12140783
Biochem J. 1988 Jan 1;249(1):143-8
2829849
Brain Res. 1992 Jan 20;570(1-2):333-40
1617424
Biochim Biophys Acta. 1978 Feb 10;522(2):434-42
623770
J Biol Chem. 2001 Oct 12;276(41):37794-801
11500487
Curr Opin Pharmacol. 2008 Feb;8(1):14-9
18061540
Anal Biochem. 1999 Jul 15;272(1):1-7
10405286
J Neurochem. 1993 Dec;61(6):2303-10
8245981
Bipolar Disord. 2007 Sep;9(6):561-70
17845270
Neurosci Lett. 2002 Aug 30;329(2):243-5
12165422
Basic Clin Pharmacol Toxicol. 2007 May;100(5):356-9
17448124
Int J Neuropsychopharmacol. 2001 Mar;4(1):47-64
11343630
Science. 1992 Oct 23;258(5082):607-14
1411571
Brain Res Bull. 2001 Jul 15;55(5):625-9
11576759
Biol Psychiatry. 2007 Jul 1;62(1):7-16
17240360
J Biol Chem. 2001 Aug 24;276(34):31674-83
11418608
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5149-53
7761465
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):347-54
12506095
Pharmacogenet Genomics. 2007 Aug;17(8):605-17
17622937
J Neurochem. 2002 Jul;82(1):137-45
12091474
Bipolar Disord. 2008 Jun;10(4):453-9
18452441
J Biol Chem. 2000 Mar 17;275(11):7583-90
10713065
Mol Genet Metab. 2004 May;82(1):87-92
15110328
Biol Psychiatry. 2004 Mar 15;55(6):570-7
15013825
Neuropsychopharmacology. 2007 Oct;32(10):2173-83
17299510
Int J Neuropsychopharmacol. 2004 Dec;7(4):387-90
15315719
Nature. 1997 Apr 24;386(6627):824-7
9126739
Pharmacopsychiatry. 2005 Jul;38(4):166-70
16025419